An exclusive focus on regulatory issues means we are ignoring a crucial longer-term question: the global competitiveness of the European ICT sector, says Martin Fransman.
UK pharmaceutical companies last year supported has nearly 14 per cent fewer PhD studentships and almost 25 per cent fewer postdoctoral grants than in 2003.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.